Bausch & Lomb (BLCO) EPS (Weighted Average and Diluted) (2021 - 2026)
Bausch & Lomb (BLCO) reported EPS (Weighted Average and Diluted) of -$0.2 for Q1 2026, up 66.67% on a YoY basis from -$0.12 in Q1 2025, and down 17.65% quarter-over-quarter from -$0.17 in Q4 2025.
Bausch & Lomb (BLCO) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Bausch & Lomb has reported EPS (Weighted Average and Diluted) for 6 years, with the latest figure at -$0.2 in Q1 2026.
- For the quarter ending Q1 2026, EPS (Weighted Average and Diluted) rose 66.67% year-over-year to -$0.2; the trailing twelve-month figure through Mar 2026 stood at -$0.63 (up 38.83% YoY), and the FY2025 full-year result was -$1.02, down 13.33% from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 stood at -$0.2, down from -$0.17 in the prior quarter.
- The five-year high for EPS (Weighted Average and Diluted) was $0.06 in Q1 2022, with the low at -$0.6 in Q1 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.18 across 5 years, with a median of -$0.16 in 2023.
- Annual changes were most pronounced in 2024 — EPS (Weighted Average and Diluted) surged 104.17% — and 2025, when it slumped 1600.0%.
- Bausch & Lomb's EPS (Weighted Average and Diluted) stood at -$0.05 in 2022, then tumbled by 200.0% to -$0.15 in 2023, then soared by 93.33% to -$0.01 in 2024, then tumbled by 1600.0% to -$0.17 in 2025, then retreated by 17.65% to -$0.2 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.2 (Q1 2026), -$0.17 (Q4 2025), and -$0.08 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 148.09 Bn | 143.69 Bn | 1.83 Bn | 2.28 |
| 2 | Becton Dickinson | 41.00 Bn | 39.99 Bn | 2.15 Bn | -1.11 |
| 3 | Medline | 30.38 Bn | 36.22 Bn | 1.84 Bn | 0.16 |
| 4 | Resmed | 28.22 Bn | 26.56 Bn | 890.98 Mn | 2.74 |
| 5 | West Pharmaceutical Services | 23.72 Bn | 23.19 Bn | 296.40 Mn | 1.92 |
| 6 | Solventum | 13.33 Bn | 13.33 Bn | 1.10 Bn | 0.07 |
| 7 | Cooper Companies | 13.12 Bn | 12.99 Bn | 735.40 Mn | -0.40 |
| 8 | Align Technology | 12.86 Bn | 11.80 Bn | 736.59 Mn | 1.57 |
| 9 | Baxter International | 10.51 Bn | 8.47 Bn | 891.00 Mn | -0.03 |
| 10 | Bausch & Lomb | 5.32 Bn | 5.12 Bn | 973.00 Mn | -0.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.20 |
| Dec 31, 2025 | -0.17 |
| Sep 30, 2025 | -0.08 |
| Jun 30, 2025 | -0.18 |
| Mar 31, 2025 | -0.60 |
| Dec 31, 2024 | -0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | -0.43 |
| Mar 31, 2024 | -0.48 |
| Dec 31, 2023 | -0.15 |
| Sep 30, 2023 | -0.24 |
| Jun 30, 2023 | -0.09 |
| Mar 31, 2023 | -0.26 |
| Sep 30, 2022 | -0.05 |
| Jun 30, 2022 | 0.01 |
| Mar 31, 2022 | 0.06 |
| Dec 31, 2021 | 0.15 |
| Sep 30, 2021 | 0.17 |
| Jun 30, 2021 | 0.13 |
| Mar 31, 2021 | 0.08 |